Jianchang Lin, Ph.D., is Principal Statistician at Takeda Pharmaceuticals, with extensive experience in oncology drug clinical development, including leading successful NDA/MAA submissions and worldwide drug approvals. Dr. Lin's research interests include Bayesian methodologies, survival analysis and Bayesian adaptive designs, and their application in clinical trials.
Bushi Wang, Ph.D., is a biostatistician at Boehringer Ingelheim Pharmaceuticals, Inc. He researches clinical trials across different therapeutic areas and different phases, largely focusing on late stage oncology and cardiovascular trials, supporting approval. He is co-founder of the Multiple Comparison Procedures Society, a .U.S organization supporting the international MCP conferences.
Xiaowen Hu, Ph.D., is Assistant Professor in the Department of Statistics, Colorado State University. Her research interests include spatial analysis, time series analysis, Bayesian analysis, and stat
